Somatostatin and octreotide prevented hypoxia-induced gut permeability increases in human colon tissue, blocking bacterial movement across the intestinal wall.
52% permeability increase blockedSomatostatin peptides completely prevented the 52% increase in gut permeability caused by oxygen deprivation in human colon tissue
What the researchers found
Chemical hypoxia (using DNP) increased paracellular permeability in human colon by 52% (p = 0.003). Both somatostatin (2 μM) and octreotide (0.2 μM) prevented this increase whether given before or after the hypoxic insult.
In rat colon, hypoxia increased total epithelial conductance by 18% (p = 0.016) and macromolecule permeability (FITC-dextran movement) by 43% (p = 0.01). Octreotide pretreatment at 0.2 μM completely prevented both changes.
The mechanism involves IK channels (intermediate conductance potassium channels, KCa3.1/KCNN4) on the basolateral side of the epithelium. Hypoxia activates these channels, opening the paracellular pathway. Somatostatin and octreotide inhibit IK channels, keeping the gut barrier intact.
Why it matters
During abdominal surgery, blood flow to the gut can be compromised, making the gut wall leaky. Bacteria and toxins then cross into the bloodstream, potentially causing sepsis, a leading cause of surgical complications and death. If octreotide can prevent this gut leakiness, it could be given during surgery as a protective measure.
The numbers in context
- Human colon GS: 52% increase with hypoxia (p = 0.003)
- SOM (2 μM): prevented GS increase whether given before or after hypoxia
- OCT (0.2 μM): prevented GS increase whether given before or after hypoxia
- Rat colon GT: 18% increase with hypoxia (p = 0.016)
- Rat colon FITC flux: 43% increase with hypoxia (p = 0.01)
- OCT pretreatment: completely prevented both rat colon changes
How the study worked
Researchers used isolated human colon tissue (Ussing chamber technique) and rat distal colon. Chemical hypoxia was induced using 2,4-dinitrophenol (DNP, 100 μM). They measured paracellular shunt conductance (GS) in human tissue and total epithelial conductance (GT) plus macromolecule flux (FITC-dextran 4000) in rat tissue. Somatostatin and octreotide were tested both as pretreatment and rescue treatment.
Who was studied
Isolated human colon tissue and rat distal colon in Ussing chamber experiments
What this study cannot tell us
These are ex vivo experiments using isolated tissue, not in vivo animal or human studies. The chemical hypoxia model (DNP) is a simplification of actual surgical ischemia-reperfusion. In a living patient, systemic factors (blood pressure, immune responses, anesthesia drugs) would add complexity. The protective effect has not been tested in an actual surgical setting. The somatostatin and octreotide concentrations used may or may not be achievable in vivo.
How to read the evidence
Rated moderate: well-designed ex vivo study using human tissue with clear mechanistic data, but needs in vivo confirmation.
When this study was published
Published in 2024. Octreotide is an established drug that could potentially be studied for this new use relatively quickly.
The bigger picture
During abdominal surgery, blood flow to the gut can be compromised, making the intestinal wall leaky. Bacteria then enter the bloodstream, causing sepsis — a leading cause of surgical deaths. Octreotide is already FDA-approved for other uses, making repurposing feasible.
Questions still open
- Would octreotide reduce surgical sepsis rates in a clinical trial?
- Does the timing of administration matter in real surgical settings?
Common questions
What causes gut leakiness during surgery?
Could octreotide prevent surgical infections?
Read the original research
Somatostatin peptides prevent increased human colonic epithelial permeability induced by hypoxia.
American journal of physiology. Gastrointestinal and liver physiology, 327(5), G701-G710
Citation
Rajput, Ibrahim; Rajendran, Vazhaikkurichi M; Nickerson, Andrew J; Lodge, J Peter A; Sandle, Geoffrey I. (2024). Somatostatin peptides prevent increased human colonic epithelial permeability induced by hypoxia.. American journal of physiology. Gastrointestinal and liver physiology, 327(5), G701-G710. https://doi.org/10.1152/ajpgi.00057.2024